Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies

BACKGROUND: Since the beginning of the novel coronavirus (SARS-CoV-2) disease outbreak, there has been an increasing interest in discovering potential therapeutic agents for this disease. In this regard, we conducted a systematic review through an overview of drug development (in silico, in vitro, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mousavi, Sarah, Zare, Shima, Mirzaei, Mahmoud, Feizi, Awat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527439/
https://www.ncbi.nlm.nih.gov/pubmed/36199815
http://dx.doi.org/10.1155/2022/2044282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527439/
https://www.ncbi.nlm.nih.gov/pubmed/36199815
http://dx.doi.org/10.1155/2022/2044282

Ejemplares similares